Skip to main content

Table 3 Demographic and baseline disease condition

From: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

Patient No. Arm Age (years) Height (cm) Weight (kg) Smoking/Tobacco No. of cigarettes/Chews Revascularization details Grade of disease*
S001 Placebo 35 161 56 Past tobacco chewer 6 Right transfemoral proximal & distal thromboembolectomy with proximal tibial artery III6
S004 Placebo 37 165 67.2 Ex-Smoker 24 No II4
S005 BM-MSC 40 171 70.2 Ex-Smoker 10 No III5
S007 BM-MSC 43 169 65 Ex-Smoker 48 Bypass surgery in left femoral artery II4
S008 Placebo 32 166 42 Ex-Smoker 24 No III5
S009 BM-MSC 46 169 60 Ex-Smoker 24 No III6
S010 BM-MSC 57 160 42 Ex-Smoker 48 Femoropopliteal bypass above the knee II4
S102 Placebo 45 174 72 Ex-Smoker 25 Right common femoral artery to anterior tibial artery reversed Gsv bypass III5
S104 BM-MSC 44 159 63 Smoker 45 No III5
S106 Placebo 32 164 71 Ex-Smoker 23 No III5
S301 Placebo 43 167 62 Ex-Smoker 4 No III6
S302 BM-MSC 37 165 62 Ex-Smoker 20 No III6
S303 BM-MSC 53 172 69 Ex-Smoker 20 No II4
S304 Placebo 59 162 60 Ex-Smoker 15 No III6
S305 Placebo 57 167 70 Ex-Smoker 15 Right popliteal artery exploration II4
S306 BM-MSC 46 170 46 Ex-Smoker 20 No III5
S307 Placebo 54 165 50 Ex-Smoker 50 Femoropopliteal artery bypass above knee III5
S308 BM-MSC 41 157 50 Ex-Smoker 20 No III5
S402 BM-MSC 60 170 55 Ex-Smoker 23 Femoro - popliteal bypass III5
S403 Placebo 36 167 60 Ex-Smoker 5 No III5
  1. *Grade of disease classified according to Rutherford criteria.
\